Immunoprecise Antibodies Ltd

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Immunoprecise Antibodies Ltd
TickerHYFT
CIK #0001715925
CUSIP602687105
SectorLife Sciences - Pharmaceutical Preparations
Address880 - 580 Hornby Street, Vancouver, BC V6C3B6
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Immunoprecise Antibodies Ltd 2024-07-30 2.0 M Exemption: 506(b) · Remaining: $1,000,000 · Duration: One year or less · Commission: $210,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001715925] 6-K
[0001715925] D
[0001715925] SC 13D
[0001715925] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Ingalls & Snyder LLC Immunoprecise Antibodies Ltd [2024-02-27] 5.01
Charmquark TWEE Immunoprecise Antibodies Ltd [2024-01-10] 6.4
Ingalls & Snyder LLC Immunoprecise Antibodies Ltd [2023-07-07] 4.22
13F Ownership Over TimeHoldersShares Held
2026-03-31 27 4,531,759
2025-12-31 30 2,326,091
2025-09-30 28 1,784,665
Form 13F Holdings
Firm Period DFND Voting Shares
Gradient Capital Advisors LLC [2026-06-30] SOLE 0 26,551
West Paces Advisors Inc [2026-06-30] SOLE 1,665 1,665
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com